Published in Hepatitis Weekly, September 21st, 1998
Researchers from a prominent transplantation database found that liver recipients who had hepatitis C virus (HCV) titers of less than 1x106 vEq/mL experienced a significantly higher five-year survival than those with titer values of greater than 1x106.
"This study suggests that the outcome of recurrent HCV infection can, at least in part, be predicted by pretransplantation levels of HCV RNA," Michael Charlton and colleagues wrote ("Predictors of Patient and Graft Survival Following Liver...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.